Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-23

FDA Approved: RUFINAMIDE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approval of a generic Rufinamide (ANDA 207363) for seizures associated with Lennox-Gastaut syndrome, enabling generic access.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rufinamide (Rufinamide)

Snippet

ORIG AP for RUFINAMIDE (RUFINAMIDE)